Guidance for VCA Deceased Donor Authorization (Resolution 7)

Slides:



Advertisements
Similar presentations
OPTN OPO Committee Spring 2012 Regional Meeting Update.
Advertisements

Modify ABO Subtyping References for Consistency Operations and Safety Committee November 12-13, 2014.
Policy Oversight Committee (POC) Report OPTN/UNOS Board of Directors Yolanda Becker, MD, Chair Sue Dunn, RN, BSN, MBA, Vice Chair November 12-13, 2014.
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda.
Guidance to Organ Procurement Organizations for Allocation of Heart-Lung Blocks (Resolution 12) OPTN/UNOS Thoracic Organ Transplantation Committee Dr.
Recognizing Seasonal and Geographically Endemic Infections in Organ Donors: Considerations during Living Donor Evaluation (Resolution 16) Ad Hoc Disease.
Top 5 OPTN Policy Violations
Todd Franzen, MPA Community Relations Team Leader.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Proposal to Require the Collection of Serum Lipase for all Pancreas Donors (Resolution 5) Pancreas Transplantation Committee Jonathan Fridell, MD, Chair.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Collaborating for Life: The Organ and Tissue Donation Process Presented by: Liz Lowry, Hospital Services Coordinator.
OPTN OPTN/UNOS Ethics Committee Spring 2012 Regional Meeting Update Chair, Alexandra Glazier, MPH, JD Vice-Chair, Peter Reese, MD.
Addressing the Requirements Outlined in the HIV Organ Policy Equity Act Organ Procurement Organization Committee Fall 2014.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
Introduction Organ Transplantation Program Update Advisory Committee on Organ Transplantation November 17, 2015 Melissa Greenwald, MD Acting Director Division.
1 Proposal to Increase Committee Terms to Three Years Policy Oversight Committee (POC) Fall 2015.
1 List Covered Body Parts Pertaining to Vascularized Composite Allografts (VCAs) VCA Transplantation Committee Spring 2016.
1 Vascularized Composite Allograft (VCA) Transplantation Committee Fall 2015 Update.
White Paper: Ethical Considerations of Imminent Death Donation
Lewis Teperman, MD Regional Councillor
Pediatric Transplantation Committee
Julie Heimbach, MD Regional Councillor
Rewrite of Article II: Board of Directors
Vascularized Composite Allograft (VCA) Transplantation Committee
Revisions to Pediatric Emergency Membership Exception
A White Paper Addressing Financial Incentives for Organ Donation
Organ, Eye and Tissue Donation in New York
Organ Procurement Organization Committee Fall 2014
Guidance on Optimizing VCA Recovery from Deceased Donors
Vascularized Composite Allograft (VCA) Transplantation Committee
OPO Committee Spring 2018.
Thoracic Organ Transplantation Committee
One Legacy Organ Donation
Organ Procurement Organization Committee Report
Thoracic Organ Transplantation Committee Spring 2015
Membership and Professional Standards Committee
Proposal to Require the Reporting of Aborted Living Donor Organ Recovery Procedures (Resolution 19) Living Donor Committee Mary Amanda Dew, PhD.
Christie Thomas, MD, FRCP, FASN, FAHA Regional Councillor
Vascularized Composite Allograft (VCA) Transplantation Committee
OPTN/UNOS Thoracic Organ Transplantation Committee Dr. Joe Rogers
Minority Affairs Committee Update
Eliminate the Use of Regions in VCA Distribution
Modify HOPE Act Variance to Include Other Organs
Action Items from the Kidney Transplantation Committee
VCA Data Collection and Submission
OPTN/UNOS Ethics Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Guidance on Effective Practices in Broader Distribution
Vascularized Composite Allograft (VCA) Transplantation Committee
David Reich, M.D., FACS Regional Councillor
OPO Committee Fall 2014.
OPO Committee Fall 2014.
Living Donor Committee Spring 2014
Minority Affairs Committee Update
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft Transplantation Committee Fall 2014
Living Donor Committee
Living Donor Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Imminent and Eligible Death Data Definitions Change Effective Date
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
White Paper: Ethics of Deceased Donor Organ Recovery without Requirement for Explicit Consent or Authorization Ethics Committee.
OPO Committee Fall 2014.
White Paper: Split Versus Whole Liver Transplantation
Vascularized Composite Allograft (VCA) Transplantation Committee
VCA Committee Update Spring 2015.
Presentation transcript:

Guidance for VCA Deceased Donor Authorization (Resolution 7) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid, MD, Chair

Guidance for VCA Deceased Donor Authorization July 3, 2014 VCAs were classified as “covered human organs” under the OPTN Final Rule Prior to that time, VCAs were not considered an organ and fell under the U.S. Food and Drug Administration Individuals enrolling in donor registries likely did not consider VCAs in decision-making On July 3, 2014, VCAs were classified as “covered human organs” under the OPTN Final Rule. New OPTN Policies and Bylaws regarding VCAs were effective at the same time. However, prior to this date, federal regulation and the OPTN Bylaws and Policies did not include VCAs as an “organ”. Covered human organs prior to that time included a kidney, liver, heart, lung, pancreas, or intestine (including the esophagus, stomach, small or large intestine, or any portion of the gastrointestinal tract). These human organs were likely the scope of the general public’s understanding of an organ that may be used in a transplant procedure. Additionally, these organs were likely the scope considered when an individual entered a decision regarding donor authorization in a recognized donor registry, and VCAs were likely not considered in decision-making. The goal of this guidance document is to provide support to Organ Procurement Organizations (OPOs) and other designated requestors, transplant hospitals, staff at local donor hospitals and administrators, as well as the general public.

# 1 – Increase the number of transplants Strategic Plan # 1 – Increase the number of transplants Increase the number of organ donors Provide clear and accurate information on VCA deceased donor authorization Alignment with the OPTN Strategic Plan is noted here to maximize the number of donors and transplants.

Guidance for VCA Deceased Donor Authorization Transparency in donation request Guidance on obtaining explicit and specific authorization for VCA recovery The VCA Committee sought to: Ensure of this transparency in the donation request Require explicit and specific authorization for VCA from deceased donors, whether given by the donor prior to death, or by family as surrogate decision makers after death, and Authorization for VCA donation should not be assumed under the general term “organ” donation.

Guidance for VCA Deceased Donor Authorization VCA Committee collaborated with the following groups: OPO Committee Minority Affairs Committee Transplant Coordinators Committee Patient Affairs Committee Ethics Committee Living Donor Committee Association of Organ Procurement Organizations The guidance document was a collaborative effort by the VCA and Ethics Committees. Review and input was sought by seven other groups identified on the slide. Feedback was very positive and the consensus was the guidance document would be helpful to the transplant community and the public regarding deceased VCA donor authorization.

Overall Project Impact Product Guidance Document Target Population Impact: OPOs, transplants hospitals, designated requesters, staff at donor hospitals, and the public Total IT Implementation Hours 0/10,680 Total Overall Implementation Hours 25/17,885

Resolution 7, page 16 RESOLVED, that the guidance document entitled, “Guidance for VCA Deceased Donor Authorization”, is hereby approved, effective November 13, 2014.